BlackRock
FNCH

BlackRock’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

BlackRock’s Portfolio FNCH Stock Details FNCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-327
Closed -$850 – 5446
2024
Q1 		$850 Sell
327
-14
-4% -$39 ﹤0.01% 5209
2023
Q4 		$1.23K Hold
341
– – ﹤0.01% 5257
2023
Q3 		$1.77K Hold
341
– – ﹤0.01% 5303
2023
Q2 		$2.91K Sell
341
-2,120
-86% -$21.8K ﹤0.01% 5351
2023
Q1 		$29K Buy
2,461
+68
+3% +$902 ﹤0.01% 5206
2022
Q4 		$34.5K Buy
2,393
+45
+2% +$1.5K ﹤0.01% 5302
2022
Q3 		$117K Buy
2,348
+123
+6% +$8.55K ﹤0.01% 5133
2022
Q2 		$189K Sell
2,225
-11,273
-84% -$964K ﹤0.01% 5048
2022
Q1 		$2.04M Buy
13,498
+305
+2% +$70.4K ﹤0.01% 4383
2021
Q4 		$3.95M Buy
13,193
+282
+2% +$108K ﹤0.01% 4096
2021
Q3 		$5.04M Buy
12,911
+363
+3% +$155K ﹤0.01% 3955
2021
Q2 		$5.3M Buy
12,548
+7,359
+142% +$3.19M ﹤0.01% 3855
2021
Q1 		$2.52M Buy
+5,189
New +$2.64M ﹤0.01% 4219

Other funds holding FNCH

LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return

BlackRock's FNCH Position: Q2 2024 in Review

BlackRock sold out of Finch Therapeutics Group, Inc. Common Stock (FNCH) in Q2 2024, closing a stake of 327 shares — an estimated $850 sold.

BlackRock first reported a position in FNCH in Q1 2021 and held it in 13 quarters. The position peaked at $5.3M in Q2 2021. 1 fund tracked by Wall St. Rank holds FNCH as of Q2 2024.

  • BlackRock reported no remaining Finch Therapeutics Group, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • BlackRock sold 327 Finch Therapeutics Group, Inc. Common Stock shares in Q2 2024, an estimated $850.
  • BlackRock first reported a position in Finch Therapeutics Group, Inc. Common Stock in Q1 2021 and held it in 13 quarters.
  • BlackRock's Finch Therapeutics Group, Inc. Common Stock position peaked at $5.3M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Finch Therapeutics Group, Inc. Common Stock as of Q2 2024.

Based on BlackRock's 13F filing for Q2 2024, filed 13 Aug 2024.